Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation Using Intragen Fractional Radiofrequency With NeuViVa for the Treatment of Vaginal Laxity and Urogynecology Symptoms.

NCT03280446 is registered in ClinicalTrials.gov with SHERRY Thomas as lead sponsor.

NCT NCT03280446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03280446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation Using Intragen Fractional Radiofrequency With NeuViVa for the Treatment of Vaginal Laxity and Urogynecology Symptoms.
Lead sponsor
SHERRY Thomas
Phase
Not applicable
Overall status
Unknown status
Start date
August 23, 2017
Completion date
August 31, 2019
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sexual dysfunction, urinary incontinence, vaginal laxity